The largest database of trusted experimental protocols

45 protocols using gm csf

1

Quantifying GM-CSF Neutralizing Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Neutralizing activity of plasma against GM-CSF was performed by assessing STAT5 phosphorylation in cells stimulated with GM-CSF in the presence of plasma from patients or controls. Briefly, PBMCs (1 × 106 cells/ml) were cultured in complete RPMI 1640 with 10% FCS with plasma from normal subjects or patients and left unstimulated or stimulated with recombinant human GM-CSF (Peprotech) for 30 min at 37 °C. Monocytes were identified by CD14 (BD Pharmingen) surface staining before being fixed and permeabilized for intracellular staining with p-STAT5 (Y694) Ab (BD Bioscience), as described previously [3 ].
In order to approximate the IC50 (concentration of antibodies responsible for 50% of inhibition of GM-CSF-induced STAT5 phosphorylation), the patient plasmas were used at different dilutions (diluted in AB serum from 0.01 to 30%) with a constant concentration of GM-CSF for stimulation (10 ng/ml).
In order to assess the EC50 (concentration of GM-CSF responsible for 50% of STAT5 phosphorylation in the presence of antibodies), the volume of plasma was chosen to get a constant final concentration of antibodies in each tube at 10 MMAU (completed with AB serum); stimulation with GM-CSF varied from 10–1 to 104 ng/ml.
Data were collected using a BD LSR Fortessa (BD Biosciences), analyzed using FlowJo software (TreeStar), and graphed with Prism8 (GraphPad).
+ Open protocol
+ Expand
2

Detailed Protocol for Mouse Bone Marrow-Derived Dendritic Cell Culture and Stimulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Mouse bone marrow-derived DCs were generated as previously described [10 (link)]. Briefly, bone marrow precursors were cultured in complete IMDM (10% FBS, antibiotics and 2-mercaptoethanol) containing 3.3 ng/ml GM-CSF (BD Biosciences, San Jose, USA) or 1% conditioned media from GM-CSF-secreting B7H1 cells. At day 6–8, cDCs were stimulated with LPS (100 ng/ml), R848 (1 μg/ml), or CpG 1826 (10 μg/ml) and harvested after 1.5 hours for Western Blot and 6 hours for RT-PCR, while supernatants and cells were collected after 24 hours for ELISA and Flow analysis. Anti-IFNAR (10 μg/ml, clone MAR1–5A3, Leinco Technologies I-400 or Gentex GTX14637) or isotype control antibody (10 μg/ml, IgG1, Leinco Technologies I-102 or Gentex GTX35014) were added 24 hours and again 30 minutes before or 1 hour before TLR stimulation. ERK inhibitor (10 μM, PD98059, Cell Signaling #9900) was used 30 minutes before TLR stimulation. 1μg/ml anti-IL-27 (Polyclonal goat IgG, R&D AF1834) or 1μg/ml IgG control antibodies (R&D AB-108-C) were added one hour prior to TLR stimulation.
+ Open protocol
+ Expand
3

Cytokine Profiling by ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The concentrations of IL-6, IL-8, GM-CSF, G-CSF, TNF-α, and CCL2 in cell supernatant were measured with a sandwich enzyme-linked immunosorbent assay (ELISA) using OptEIA Set human IL-6, IL-8, GM-CSF, TNF-α, and CCL2 (BD Biosciences, San Diego, CA, USA) and G-CSF (Abfrontier, Seoul, Korea) according to the manufacturer's instructions.
+ Open protocol
+ Expand
4

Rhinovirus-Induced Maturation of Monocyte-Derived DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
Peripheral blood mononuclear cells (PBMCs) were isolated through Ficoll-Hypaque (Sigma, St Louis, MO) density centrifugation. CD14+ cells were enriched (>95%) from PBMCs using positive magnetic affinity column purification (Miltenyi Biotec, Auburn, CA). Cells were suspended in STEM PRO-34 medium (Invitrogen, Carlsbad, CA) supplemented with GM-CSF (1000 U/ml; BD Pharmingen, San Diego, CA), IL-4 (1000 U/ml; BD Pharmingen), penicillin (10,000 U/ml), streptomycin (10 μg/ml) and 10% autologous serum and maintained at 37° C in 5% CO2. Cells were differentiated for 5 days before analysis, with medium and supplements changed at day 3. RV-induced maturation of monocyte-derived DCs was evaluated after the application of ∼350 TCID50 of RV39. After an additional 48 hrs, cells were collected for surface expression of maturation markers. In addition, supernatants and mRNA transcripts were isolated and analyzed for expression of cytokines relevant to DC maturation status and anti-viral immunity or involved in T lymphocyte development and immune deviation.
+ Open protocol
+ Expand
5

Comprehensive NK Cell Phenotyping

Check if the same lab product or an alternative is used in the 5 most similar protocols
dNK cells were gated on as live, CD9+CD56+ cells. pbNK cells were gated on as live CD56+CD3 cells. The following Abs were used: Live/Dead discriminator (Life Technologies), CD9 (SN4 or M-L13 from eBioscience or BD Biosciences, respectively), CD56 (HCD56 from BioLegend), and CD3 (SK7) from BD Biosciences. Fibroblasts and macrophages were identified using CD10 (HI10a from BioLegend) and CD14 Abs (MφP9 and HCD14 from BD Pharmingen and BioLegend), respectively. The following Abs were used to stain KIRs: UPR1 (KIR2DL5) from BioLegend and Carlos Vilches (33 (link)); 179315 (KIR2DS4), 143211 (KIR2DL1), and 181703 (KIR2DL4) from R&D Systems; FES172 (KIR2DS4) and EB6 (KIR2DL1/S1) from Beckman Coulter; CHL (KIR2DL2/3/S2) from BD Pharmingen; DX9 (KIR3DL1) from BioLegend; NKVFS1 (KIR2DL1/2/3/S1/2/4) from Abcam; 5.133 (KIR3DL2) from Marco Colonna (34 (link)); and FLAG Abs from Sigma-Aldrich. Intracellular staining was performed according to the manufacturers’ instructions with Abs against Ki647 (BD Pharmingen), CCL3 (R&D Systems), and GM-CSF (BD Biosciences).
+ Open protocol
+ Expand
6

Eosinophil/Basophil Progenitor Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Enriched CD34+ progenitors (8000 cells/well) were cultured in duplicates in 0.9% methylcellulose (Sigma Aldrich, St. Louis, MO, USA) with Iscove's 2+ (modified Dulbecco's medium (Gibco, Burlington, Ontario, Canada) supplemented with FBS, penicillin–streptomycin, and 2-ME) and IL-3 (1 ng/mL), IL-5 (1 ng/mL), or GM-CSF (10 ng/mL; BD Biosciences, Mississauga, ON, Canada) in the presence or absence of TSLP (10 ng/mL; PeproTech, Rocky Hill, NJ, USA) in 12-well plates (Corning Costar, Corning, NY, USA). In some experiments, cells were treated with anti-TSLP (Amgen, Seattle, WA, USA), anti-TSLPR (R&D Systems, Minneapolis, MN, USA), anti-TNFα (R&D), or isotype control (each at 10 µg/mL). Treatment with the indicated stimulatory/inhibitory conditions had no effects on cell viability as determined by trypan blue exclusion. Cultures were incubated for 14 days (37°C, 5% CO2). Eo/B CFU were enumerated using inverted light microscopy (colonies were defined as tight, granular clusters ≥40 cells).
+ Open protocol
+ Expand
7

Bone Marrow-Derived Dendritic Cell Activation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Bone marrow cells were isolated from the tibias and femurs of B6 mice, cultured in vitro in RPMI-1640 with 10% FCS, 2 mM L-glutamine, 30 mM HEPES, 0.05 mM β-mercaptoethanol and 0.05 mg ml−1 gentamycin, supplemented with 1,000 U ml−1 GM-CSF (BD Biosciences) and 100 U ml−1 IL-4 (eBioscience). Medium was changed on day 2 and the top half of the medium was changed on day 5 of culture. On day 7, BMDCs were harvested, enriched for CD11c+ cells (Miltenyi Biotec) and activated overnight with NIH 3T3 cells expressing CD40L70 (link) (provided by R. Lapoint, University of Montreal). Activated BMDCs were pulsed with 50 μg ml−1 of β-gal721-739 (AENLSVTLPAASHAIPHLT, GenScript) for 3 h, washed and 1 × 105 BMDCs were injected IV.
+ Open protocol
+ Expand
8

SKNO-1 Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
SKNO-1 cells were purchased from DSMZ (Braunschweig, Germany) and cultured in RPMI 1640 with 20% FCS, 1% penicillin-streptomycin, and 10 ng ml-1 GM-CSF (BD Biosciences).
+ Open protocol
+ Expand
9

Quantifying Cytokine Secretion in RevCAR T Cell Assays

Check if the same lab product or an alternative is used in the 5 most similar protocols
Triplets of 5*103 tumor cells were seeded in a 96-well cell culture plate and cultivated with RevCAR T cells in the presence or absence of RevTMs. Supernatants of co-culture assays were harvested after 24 or 48 h, as indicated in the figure legends. Analysis of secreted cytokines was performed using the OptEIA Human IFN-γ (Cat#555142), GM-CSF (Cat#555126), IL-2 (Cat#555190), and TNF (Cat#555212) ELISA Sets purchased from BD BioSciences or the human MACSPlex Cytokine 12 Kit (Miltenyi Biotec #130-099-169) as described in the manufacturer’s manuals.
+ Open protocol
+ Expand
10

Isolation and culture of murine neutrophils and dendritic cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Protocols were approved by the Institutional Animal Care and Use Committee (IACUC) at the National University of Singapore. Bone marrow derived neutrophils and DC were generated as previously described [16 (link)]. In brief, neutrophils were derived by positive selection with anti-Ly6G microbead kit (Miltenyi Biotec, Germany) and were at least 95% positive for Ly6G, by flow cytometry. DCs were obtained from the bone marrow derived cells after 9 days of culture (with fresh media replacement every other day) in RPMI 1640 supplemented with 10% heat-inactivated FCS, 50 μM 2-mercaptoethanol, 1% penicillin, streptomycin, glutamine, MEM (minimum essential medium), and 0.1% sodium pyruvate with 40 ng/mL of GM-CSF (BD Bioscience, USA). The DCs were at least 95% positive for CD11c, by flow cytometry. The media used for both neutrophil and DC experiments were DMEM supplemented with 10% fetal bovine serum (Hyclone, USA), 2 mM L-glutamine (Gibco, Japan), 50 μg/mL penicillin G (Sigma Aldrich, USA), and 50 μM of 2-mercaptoethanol (Merck, Germany) with the addition of 20 ng/mL of GM-CSF for the culture of dendritic cells.
T lymphocytes were isolated from spleens of naive C57BL/6 mice and enriched with the EasySepTM T cell isolation kit (STEMCELL Technologies, Vancouver, Canada). The desired fraction was about 95–98% CD3 positive.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!